The WHO announced 70,000 doses of Merck's Ervebo vaccine have reached the DRC for a Phase 3 trial targeting the Bundibugyo virus strain. This study aims to evaluate effectiveness against the newly cir
The U.S. government is fast-tracking veterinary drug approvals and funding to combat a screwworm outbreak threatening the cattle industry, despite staffing shortages. FDA authorized treatments from El
Merck executives are exploring molnupiravir as an Ebola treatment amid a worsening outbreak in the DRC. The company also noted potential applications for its existing Ebola vaccine technology against
ChemBrief